NCT05418049 - Evaluating the Neurophysiologic and Clinical Effects of Single Dose Drug Challenge | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 8, 2022

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions

Fragile X Syndrome

Interventions

DRUG

Baclofen

30mg - Supplied as 10mg and 20mg tablets

DRUG

Memantine

two 10 mg tablets

DRUG

Roflumilast

250 mcg capsule

DRUG

Placebo

Placebo pill

Trial Locations (1)

RECRUITING

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Children's Hospital Medical Center, Cincinnati

OTHER